$64.760
+0.913 (+1.41%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
RPRX-Prognose durch Analyse ähnlicher Charts
Alphio's RPRX stock price prediction model matches the current Royalty Pharma PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $64.98 (+0.34%). The 1-week path is $65.76 (+1.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Royalty Pharma PLC-Aktien kaufen?
Royalty Pharma PLC is a good buy right now due to its current price of $63.86 being below the average analyst price target of $66, suggesting a potential upside of approximately 3.5%. Additionally, the company has shown strong financial performance with a year-to-date change of +64.33% and a robust gross margin of 100%. The main risk is the high RSI of 82.353, indicating that the stock may be overbought in the short term, which could lead to volatility.
RPRX schloss am Monday bei $64.76, nachdem der Kurs +1.41% gestiegen ist
Royalty Pharma PLC (RPRX) last closed at $64.7600021, gaining +1.41%. These facts feed the 1-day and 1-week RPRX price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Royalty Pharma PLC (RPRX) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf RPRX am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für RPRX
Historically the probability of a positive October return for RPRX is 64.06%. March offers the highest probability of a positive month at 100.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.